Category Archives: Erudition & Culture

European Medicines Agency Recommends Approval of Four Cancer Drugs

The European Medicines Agency (EMA) recently issued positive opinions for four novel cancer therapies, signifying a major advancement in the fight against various malignancies. These approvals offer promising treatment options for patients with urothelial carcinoma, lymphomas, prostate cancer, and chronic myelogenous leukemia (CML).

Sofdra™ Receives FDA Approval for Primary Axillary Hyperhidrosis

Botanix Pharmaceuticals Ltd (ASX:BOT) is pleased to announce the U.S. Food and Drug Administration (FDA) approval of Sofdra™ (sofpironium) topical gel, 12.45%. This marks a significant milestone for both Botanix and patients struggling with primary axillary hyperhidrosis, a condition characterized by excessive underarm sweating.

Chronic Loneliness as a Risk Factor for Stroke in Older Adults

Stroke is a leading cause of morbidity and mortality globally. Established risk factors such as hypertension and smoking play a crucial role, but they do not fully explain stroke incidence. Recent research suggests that social isolation and loneliness might be additional significant contributors, particularly for older adults. This study investigates the association between loneliness and stroke risk in a large, nationally representative sample of middle-aged and older adults in the United States. It extends beyond a single measure of loneliness by examining how changes in loneliness over time might impact stroke risk.

The Gut Feeling: How Your Stomach Talks to Your Emotions

Have you ever felt a knot in your stomach before a big presentation, or butterflies during a first date? These expressions hint at a long-suspected connection between our emotions and our digestive system. A new study led by Italian researchers has shed light on this very link, investigating how the stomach and emotions influence each other.

Tirzepatide Shows Promise for Obstructive Sleep Apnea and Obesity

Obstructive sleep apnea (OSA) is a condition where breathing repeatedly stops and starts during sleep. This can lead to serious health problems, including heart disease. People who are overweight or obese are more likely to develop OSA.

Tirzepatide is a medication being studied as a potential treatment for OSA. This study, funded by Eli Lilly, aimed to see if Tirzepatide could improve OSA and other health issues in people with moderate-to-severe OSA and obesity.